Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut R Maecke

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2011
Radiopeptide imaging and therapy in EuropeValentina Ambrosini, Melpomeni Fani, Stefano Fanti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emittersMihaela Ginj, Karin Hinni, Sibylle Tschumi, et al.
Chemical Communications (Cambridge, England)|July 16, 2008
Novel DOTA-based prochelator for divalent peptide vectorization: synthesis of dimeric bombesin analogues for multimodality tumor imaging and therapyKeelara Abiraj, Hugues Jaccard, Martin Kretzschmar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and productionHelena Uusijärvi, Peter Bernhardt, Frank Rösch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOCFlavio Forrer, Helena Uusijärvi, Daniel Storch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissuesBea Waser, Maria-Luisa Tamma, Renzo Cescato, et al.
Journal of the American Chemical Society|November 2, 2013
Hybrid bombesin analogues: combining an agonist and an antagonist in defined distances for optimized tumor targetingCarsten Kroll, Rosalba Mansi, Friederike Braun, et al.
European Journal of Pharmacology|July 21, 2010
Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor modelBeatrice Waser, Renzo Cescato, Maria-Luisa Tamma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2014
The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studiesEleni Gourni, Beatrice Waser, Pascal Clerc, et al.
Plos One|December 25, 2015
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive TumorsEleni Gourni, Coline Canovas, Victor Goncalves, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2011
Radiopeptide imaging and therapy in EuropeValentina Ambrosini, Melpomeni Fani, Stefano Fanti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2005
Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emittersMihaela Ginj, Karin Hinni, Sibylle Tschumi, et al.
Chemical Communications (Cambridge, England)|July 16, 2008
Novel DOTA-based prochelator for divalent peptide vectorization: synthesis of dimeric bombesin analogues for multimodality tumor imaging and therapyKeelara Abiraj, Hugues Jaccard, Martin Kretzschmar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and productionHelena Uusijärvi, Peter Bernhardt, Frank Rösch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOCFlavio Forrer, Helena Uusijärvi, Daniel Storch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissuesBea Waser, Maria-Luisa Tamma, Renzo Cescato, et al.
Journal of the American Chemical Society|November 2, 2013
Hybrid bombesin analogues: combining an agonist and an antagonist in defined distances for optimized tumor targetingCarsten Kroll, Rosalba Mansi, Friederike Braun, et al.
European Journal of Pharmacology|July 21, 2010
Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor modelBeatrice Waser, Renzo Cescato, Maria-Luisa Tamma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2014
The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studiesEleni Gourni, Beatrice Waser, Pascal Clerc, et al.
Plos One|December 25, 2015
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive TumorsEleni Gourni, Coline Canovas, Victor Goncalves, et al.
Pageof 9